Aurobindo Pharma
AUROPHARMA.NS
#1804
Rank
HK$72.35 B
Marketcap
HK$124.58
Share price
-3.17%
Change (1 day)
51.56%
Change (1 year)

Earnings for Aurobindo Pharma (AUROPHARMA.NS)

Earnings in 2024 (TTM): HK$4.89 Billion

According to Aurobindo Pharma 's latest financial reports the company's current earnings are HK$3.52 Billion. In 2023 the company made an earning of HK$3.87 Billion, an increase over its 2022 earnings that were of HK$2.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurobindo Pharma from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$4.89 B26.37%
2023 HK$3.87 B55.34%
2022 HK$2.49 B-38.78%
2021 HK$4.07 B-47.85%
2020 HK$7.80 B92.99%
2019 HK$4.04 B17.55%
2018 HK$3.44 B-13.37%
2017 HK$3.97 B5.61%
2016 HK$3.76 B19.84%
2015 HK$3.13 B4.56%
2014 HK$3.00 B112.18%
2013 HK$1.41 B91.27%
2012 HK$0.73 B